$3.695
+0.140 (+3.79%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de REVB por análisis de gráficos similares
Alphio's REVB stock price prediction model matches the current Revelation Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.71 (+0.39%). The 1-week path is $3.70 (+0.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Revelation Biosciences Inc?
Revelation Biosciences Inc is currently not a strong buy due to its ongoing financial losses and recent stock performance. The current price is $3.69, which is significantly down 83.77% year-to-date and 87.31% over the past year. Although the company has a potential total addressable market of $94 billion for its product Gemini, the recent earnings report showed a GAAP EPS of -5.92, indicating continued challenges in profitability. The main risk is the company's high net loss of $59.76 million for FY 2025, which raises concerns about its financial sustainability.
REVB cerró en $3.69 el Friday, tras subir +3.79%
Revelation Biosciences Inc (REVB) last closed at $3.6949999, gaining +3.79%. These facts feed the 1-day and 1-week REVB price prediction above.
Consenso de analistas
Revelation Biosciences Inc (REVB): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Revelation Biosciences Inc (REVB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de REVB, ordenadas por similitud.
Análisis de estacionalidad de REVB
Historically the probability of a positive November return for REVB is 0.00%. January offers the highest probability of a positive month at 21.31%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de REVB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $3.28 | $3.56 | $4.09 | -3.60% |
| Dec 2026 | $2.66 | $3.08 | $3.08 | -16.62% |
En 2026, se proyecta que Revelation Biosciences Inc (REVB) oscile entre $2.66 y $4.09.
Previsión mensual de Revelation Biosciences Inc para 2026
En Nov de 2026, se proyecta que Revelation Biosciences Inc promedie $3.56, con un mínimo de $3.28 y un máximo de $4.09.
En Dec de 2026, se proyecta que Revelation Biosciences Inc promedie $3.08, con un mínimo de $2.66 y un máximo de $3.08.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.